XENON PHARMACEUTICALS INC. Operating Expenses
XENON PHARMACEUTICALS INC. (XENE) reported Operating Expenses of $123.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- XENON PHARMACEUTICALS INC. operating expenses for the quarter ending 2026-06-30 was $123.16M, a 30.70% increase year-over-year.
- XENON PHARMACEUTICALS INC. operating expenses for the quarter ending 2026-03-31 was $112.33M, a 39.99% increase year-over-year.
- XENON PHARMACEUTICALS INC. operating expenses for the quarter ending 2025-12-31 was $109.77M, a 41.68% increase year-over-year.
- XENON PHARMACEUTICALS INC. operating expenses for the quarter ending 2025-09-30 was $96.34M, a 30.76% increase year-over-year.
- XENON PHARMACEUTICALS INC. operating expenses for fiscal 2025 was $380.57M, a 36.26% increase from fiscal 2024.
- XENON PHARMACEUTICALS INC. operating expenses for fiscal 2024 was $279.30M, a 30.48% increase from fiscal 2023.
- XENON PHARMACEUTICALS INC. operating expenses for fiscal 2023 was $214.05M, a 54.47% increase from fiscal 2022.
- XENON PHARMACEUTICALS INC. operating expenses for fiscal 2022 was $138.58M, a 42.23% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $123.16M 10-Q · filed 2026-08-06 | $235.48M 10-Q · filed 2026-08-06 | $345.25M derived: sum of 3 quarters · filed 2026-08-06 | $441.59M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $112.33M 10-Q · filed 2026-05-07 | $222.09M derived: sum of 2 quarters · filed 2026-05-07 | $318.43M derived: sum of 3 quarters · filed 2026-05-07 | $412.66M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $109.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $206.10M derived: sum of 2 quarters · filed 2026-02-26 | $300.33M derived: sum of 3 quarters · filed 2026-08-06 | $380.57M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $96.34M 10-Q · filed 2025-11-03 | $190.56M derived: sum of 2 quarters · filed 2026-08-06 | $270.80M 10-Q · filed 2025-11-03 | $348.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $94.23M 10-Q · filed 2026-08-06 | $174.47M 10-Q · filed 2026-08-06 | $251.94M derived: sum of 3 quarters · filed 2026-08-06 | $325.62M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $80.24M 10-Q · filed 2026-05-07 | $157.72M derived: sum of 2 quarters · filed 2026-05-07 | $231.39M derived: sum of 3 quarters · filed 2026-05-07 | $300.50M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $77.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $151.15M derived: sum of 2 quarters · filed 2026-02-26 | $220.26M derived: sum of 3 quarters · filed 2026-02-26 | $279.30M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $73.68M 10-Q · filed 2025-11-03 | $142.78M derived: sum of 2 quarters · filed 2025-11-03 | $201.82M 10-Q · filed 2025-11-03 | $255.52M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $69.10M 10-Q · filed 2025-08-11 | $128.15M 10-Q · filed 2025-08-11 | $181.84M derived: sum of 3 quarters · filed 2026-02-26 | $237.52M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $59.04M 10-Q · filed 2025-05-12 | $112.74M derived: sum of 2 quarters · filed 2026-02-26 | $168.42M derived: sum of 3 quarters · filed 2026-02-26 | $224.04M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $53.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $109.38M derived: sum of 2 quarters · filed 2026-02-26 | $165.00M derived: sum of 3 quarters · filed 2026-02-26 | $214.05M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $55.68M 10-Q · filed 2024-11-12 | $111.31M derived: sum of 2 quarters · filed 2024-11-12 | $160.36M 10-Q · filed 2024-11-12 | $203.69M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $55.62M 10-Q · filed 2024-08-08 | $104.67M 10-Q · filed 2024-08-08 | $148.01M derived: sum of 3 quarters · filed 2025-02-27 | $186.27M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $49.05M 10-Q · filed 2024-05-09 | $92.38M derived: sum of 2 quarters · filed 2025-02-27 | $130.64M derived: sum of 3 quarters · filed 2025-02-27 | $161.49M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $43.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $81.59M derived: sum of 2 quarters · filed 2025-02-27 | $112.44M derived: sum of 3 quarters · filed 2025-02-27 | $138.58M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | $38.26M 10-Q · filed 2023-11-08 | $69.11M derived: sum of 2 quarters · filed 2023-11-08 | $95.25M 10-Q · filed 2023-11-08 | $123.82M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $30.85M 10-Q · filed 2023-08-09 | $56.99M 10-Q · filed 2023-08-09 | $85.56M derived: sum of 3 quarters · filed 2024-02-29 | $109.28M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $26.14M 10-Q · filed 2023-05-09 | $54.71M derived: sum of 2 quarters · filed 2024-02-29 | $78.43M derived: sum of 3 quarters · filed 2024-02-29 | $103.15M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $28.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $52.30M derived: sum of 2 quarters · filed 2024-02-29 | $77.01M derived: sum of 3 quarters · filed 2024-02-29 | $97.43M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $23.72M 10-Q · filed 2022-11-08 | $48.44M derived: sum of 2 quarters · filed 2022-11-08 | $68.86M 10-Q · filed 2022-11-08 | $86.93M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $24.72M 10-Q · filed 2022-08-09 | $45.13M 10-Q · filed 2022-08-09 | $63.21M derived: sum of 3 quarters · filed 2023-03-01 | $79.46M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $20.42M 10-Q · filed 2022-05-10 | $38.49M derived: sum of 2 quarters · filed 2023-03-01 | $54.74M derived: sum of 3 quarters · filed 2023-03-01 | $68.77M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $18.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $34.33M derived: sum of 2 quarters · filed 2023-03-01 | $48.36M derived: sum of 3 quarters · filed 2023-03-01 | $63.47M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | $16.25M 10-Q · filed 2021-11-10 | $30.28M derived: sum of 2 quarters · filed 2021-11-10 | $45.39M 10-Q · filed 2021-11-10 | $60.32M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $14.03M 10-Q · filed 2021-08-11 | $29.14M 10-Q · filed 2021-08-11 | $44.07M derived: sum of 3 quarters · filed 2021-08-11 | $56.52M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $15.11M 10-Q · filed 2021-05-11 | $30.04M derived: sum of 2 quarters · filed 2021-05-11 | $42.49M derived: sum of 3 quarters · filed 2021-05-11 | $53.00M derived: sum of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $27.38M derived: sum of 2 quarters · filed 2021-03-01 | $37.89M derived: sum of 3 quarters · filed 2021-03-01 | $49.65M 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $12.45M 10-Q · filed 2020-11-05 | $22.96M derived: sum of 2 quarters · filed 2020-11-05 | $34.72M 10-Q · filed 2020-11-05 | $43.17M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $10.51M 10-Q · filed 2020-08-06 | $22.27M 10-Q · filed 2020-08-06 | $30.72M derived: sum of 3 quarters · filed 2020-08-06 | $44.91M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $11.76M 10-Q/A · filed 2020-05-26 | $20.21M derived: sum of 2 quarters · filed 2020-05-26 | $34.40M derived: sum of 3 quarters · filed 2020-05-26 | $41.99M derived: sum of 4 quarters · filed 2020-05-26 | ||||
| 2018-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $22.64M derived: sum of 2 quarters · filed 2020-03-09 | $30.23M derived: sum of 3 quarters · filed 2020-03-09 | $38.04M 10-K · filed 2020-03-09 | $38.02M 10-K · filed 2019-03-06 | |||
| 2018-09-30 | $14.19M 10-Q · filed 2019-11-05 | $14.18M 10-Q · filed 2018-11-06 | $21.78M derived: sum of 2 quarters · filed 2019-11-05 | $29.59M 10-Q · filed 2019-11-05 | $29.58M 10-Q · filed 2018-11-06 | $37.65M derived: sum of 4 quarters · filed 2019-11-05 | ||
| 2018-06-30 | $7.59M 10-Q · filed 2019-08-06 | $7.59M 10-Q · filed 2018-08-07 | $15.40M 10-Q · filed 2019-08-06 | $15.40M 10-Q · filed 2018-08-07 | $23.47M derived: sum of 3 quarters · filed 2019-08-06 | $32.38M derived: sum of 4 quarters · filed 2019-08-06 | ||
| 2018-03-31 | $7.81M 10-Q · filed 2019-05-07 | $7.82M 10-Q · filed 2018-05-08 | $15.87M derived: sum of 2 quarters · filed 2019-05-07 | $24.78M derived: sum of 3 quarters · filed 2019-05-07 | $32.69M derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $16.98M derived: sum of 2 quarters · filed 2019-03-06 | $24.88M derived: sum of 3 quarters · filed 2019-03-06 | $32.89M 10-K · filed 2019-03-06 | ||||
| 2017-09-30 | $8.91M 10-Q · filed 2018-11-06 | $16.82M derived: sum of 2 quarters · filed 2018-11-06 | $24.82M 10-Q · filed 2018-11-06 | $30.66M derived: sum of 4 quarters · filed 2018-11-06 | ||||
| 2017-06-30 | $7.91M 10-Q · filed 2018-08-07 | $15.91M 10-Q · filed 2018-08-07 | $21.75M derived: sum of 3 quarters · filed 2018-08-07 | $29.49M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | $8.00M 10-Q · filed 2018-05-08 | $13.84M derived: sum of 2 quarters · filed 2018-05-08 | $21.59M derived: sum of 3 quarters · filed 2018-05-08 | $28.36M derived: sum of 4 quarters · filed 2018-05-08 | ||||
| 2016-12-31 | $5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $13.58M derived: sum of 2 quarters · filed 2018-03-07 | $20.36M derived: sum of 3 quarters · filed 2018-03-07 | $26.62M 10-K · filed 2018-03-07 | ||||
| 2016-09-30 | $7.74M 10-Q · filed 2017-11-07 | $14.52M derived: sum of 2 quarters · filed 2017-11-07 | $20.78M 10-Q · filed 2017-11-07 | $26.61M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | $6.78M 10-Q · filed 2017-08-03 | $13.04M 10-Q · filed 2017-08-03 | $18.87M derived: sum of 3 quarters · filed 2018-03-07 | $23.98M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | $6.26M 10-Q · filed 2017-05-09 | $12.09M derived: sum of 2 quarters · filed 2018-03-07 | $17.20M derived: sum of 3 quarters · filed 2018-03-07 | $21.05M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $10.94M derived: sum of 2 quarters · filed 2018-03-07 | $14.79M derived: sum of 3 quarters · filed 2018-03-07 | $24.94M 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | $5.11M 10-Q · filed 2016-11-03 | $8.96M derived: sum of 2 quarters · filed 2016-11-03 | $19.11M 10-Q · filed 2016-11-03 | $23.95M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-06-30 | $3.85M 10-Q · filed 2016-08-03 | $13.99M 10-Q · filed 2016-08-03 | $18.84M derived: sum of 3 quarters · filed 2017-03-08 | $23.37M derived: sum of 4 quarters · filed 2017-03-08 | ||||
| 2015-03-31 | $10.15M 10-Q · filed 2016-05-10 | $5.22M 10-Q · filed 2015-05-12 | $14.99M derived: sum of 2 quarters · filed 2017-03-08 | $19.52M derived: sum of 3 quarters · filed 2017-03-08 | $23.44M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $9.38M derived: sum of 2 quarters · filed 2017-03-08 | $13.29M derived: sum of 3 quarters · filed 2017-03-08 | $17.26M 10-K · filed 2017-03-08 | ||||
| 2014-09-30 | $4.53M 10-Q · filed 2015-11-10 | $8.45M derived: sum of 2 quarters · filed 2015-11-10 | $12.42M 10-Q · filed 2015-11-10 | $15.98M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-06-30 | $3.92M 10-Q · filed 2015-08-13 | $7.89M 10-Q · filed 2015-08-13 | $11.45M derived: sum of 3 quarters · filed 2016-03-08 | $15.72M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-03-31 | $3.97M 10-Q/A · filed 2015-08-13 | $7.53M derived: sum of 2 quarters · filed 2016-03-08 | $11.80M derived: sum of 3 quarters · filed 2016-03-08 | |||||
| 2013-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $7.83M derived: sum of 2 quarters · filed 2016-03-08 | $17.64M 10-K · filed 2016-03-08 | |||||
| 2013-09-30 | $4.27M 10-Q · filed 2014-12-15 | $14.08M 10-Q · filed 2014-12-15 | ||||||
| 2012-12-31 | $17.46M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |